跳至主要内容
临床试验/NCT04683900
NCT04683900已完成不适用

Mediterranean Diet Intervention to Improve Gastrointestinal Function in Parkinson's Disease: a Randomized, Controlled, Clinical Trial

University of Florida2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2021年2月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
GSRS Constipation Syndrome Score

研究概览

简要总结

This is a 10-week randomized, controlled study to investigate the effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson's disease. After a 2-week run-in period, participants will be instructed to receive standard of care for constipation or receive standard of care + follow a Mediterranean diet for 8 weeks and answer daily and weekly questionnaires. Nutritional and neurological evaluations and stool samples will be collected at 0, 4 and 8 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physician-diagnosed Parkinson's disease aged 40-85 years
  • Drug naïve or on stable dosage of Parkinson's medications with no plans to change for the duration of the study protocol
  • Hoehn & Yahr stage =<2.5 in the clinical "ON" state
  • Constipation syndrome scores >=2.0 based on the GSRS
  • Consume <20 grams of fiber daily based on the Block Fruit/Vegetable/Fiber screener
  • Able to complete informed consent in English
  • Willing to maintain habitual diet through the pre-baseline period.
  • Willing to make dietary changes to follow a Mediterranean diet and/or receive standard of care for constipation during the intervention period.
  • Willing to complete daily and weekly questionnaires and 12 dietary recalls over approximately 10 weeks.
  • Able to provide stool samples during the study collection periods.
  • Willing to avoid strenuous exercise and alcohol such as beer, wine, and cocktails 24 hours prior to each of the 3 study visits.
  • Able to fast (no food or drink, except water, or decaf tea) at least 12 hours before each study visit
  • Willing to discontinue taking prebiotic, herbal, or high-dose vitamin or mineral supplements that may impact inflammation during the pre-baseline period and throughout the study protocol.

排除标准

  • Atypical or secondary Parkinsonism
  • Underweight (BMI <18.5)
  • History of deep brain stimulation (DBS) surgery
  • Regular use of enemas or suppositories to alleviate constipation (e.g., >1 time per week)
  • Use of another investigational product within 3 months of the screening visit
  • Antibiotic or probiotic supplement use within 2 months from the day of stool collection
  • Currently being treated for a physician-diagnosed GI disease or condition other than constipation, irritable bowel disease, gastroparesis, reflux or diverticular disease

结局指标

主要结局

GSRS Constipation Syndrome Score

时间窗: 10 weeks

The difference between mean change (final - baseline) in constipation syndrome scores for the Med diet versus control diet.

次要结局

  • Quality of Life Related to Digestive Health(Every week up to 10 weeks)
  • Digestive Health(Every week up to 10 weeks)
  • Fecal Microbial Diversity(Baseline (Week 0); Midpoint (Week 4); Final (Week 8))
  • Laxative Usage(Each week up to 10 weeks)
  • Fecal Microbial Quantitative Polymerase Chain Reaction (qPCR)(Baseline (Week 0); Midpoint (Week 4); Final (Week 8))
  • Stool Frequency(Each week up to 10 weeks)
  • Stool Form(Each day up to 10 weeks)
  • Intestinal Inflammation and Permeability(Baseline (Week 0); Midpoint (Week 4); Final (Week 8))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验